Navigation Links
Jazz Pharmaceuticals to Present Data From First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia
Date:6/9/2009

>

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. For further information please see http://www.JazzPharmaceuticals.com.

Jazz Pharmaceuticals "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements related to the development of Jazz Pharmaceuticals' sodium oxybate (JZP-6) product candidate for the treatment of fibromyalgia, including the timing of results from the second Phase III pivotal clinical trial and the submission of a New Drug Application to the FDA. These forward-looking statements are based on the company's current expectations and inherently involve significant risks and uncertainties. Jazz Pharmaceuticals' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to the outcomes of the company's second Phase III clinical study of sodium oxybate for the treatment of fibromyalgia and the timing of the announcement of clinical results, and risks that a New Drug Application may not be submitted, or may be delayed, and that sodium oxybate for the treatment of fibromyalgia may not be approved for marketing by regulatory authorities. These and other risk factors are discussed under "Risk Factors" in the Quarterly Report on Form 10-Q for the quarter ended March 31, 2009 filed by Jazz Pharmaceuticals with the Securities and Exchange Commission on May 7, 2009. Jazz Pharmaceuticals undertakes no duty or obligation to update any forward-l
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014 Ticket Down is a ... in Miami, FL at the Sun Life Stadium in early ... between Argentina and Brazil has is one that has continues ... rivalries are forming on a consistent basis. The rivalry ... height in the recent 2014 World Cup. To the ...
(Date:7/28/2014)... July 28, 2014 (HealthDay News) -- British researchers report ... far fewer germs around. In their experiments, the ... more germs from one person to the other than ... the more casual exchange might suffice as a cultural ... findings are published in the August issue of the ...
(Date:7/28/2014)... is enough oxygen present to support their offspring, but ... rule. Researchers at The Johns Hopkins University have now ... enabling cancers to continue to divide even without a ... that lysosomes the cell,s protein "recycling centers" ... evidence that certain drugs can halt the growth of ...
(Date:7/28/2014)... July 28, 2014 The Oakwood Foundation ... Birkhill, Wang, Songe and Associates, PC that will benefit ... tomorrows to come. , The HBWS group is ... more than $2.5 million in donations. Through their latest ... for the Oakwood Women’s Healthcare Classic for the next ...
(Date:7/28/2014)... Salt Lake City, Utah (PRWEB) July 28, 2014 ... supplements, protein powders and drinks, announced that it will ... protein drink line of products this summer. The additional ... combined with clean pure taste-free protein , Inspire Pomegranate ... Inspire Vanilla - flavor of soft-serve vanilla cone , ...
Breaking Medicine News(10 mins):Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Showdown 2Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Showdown 3Health News:'Fist Bump' May Beat Handshake for Cleanliness 2Health News:'Fist Bump' May Beat Handshake for Cleanliness 3Health News:Cell's recycling center implicated in division decisions 2Health News:Bariatric Eating Announces Three New Protein Shake Flavors 2
... May 8, 2012 Poor women and African Americans ... standards of care, leading to worse outcomes than among white ... presented by UC Irvine,s Dr. Robert Bristow at the Society ... women are benefiting equally from improvements in ovarian cancer care," ...
... , TUESDAY, May 8 (HealthDay News) -- Sperm cells ... tract by crawling along walls and swimming around corners, ... sperm cells are ejaculated, the few that actually reach ... new insight on how sperm travel could help scientists ...
... PHILADELPHIA - All cells have the ability to recycle unwanted ... But cancer cells have ramped up the system, called autophagy, ... of chemotherapy and other treatments. Now, researchers at the Perelman ... of Arts and Sciences, at the University of Pennsylvania, have ...
... By Maureen Salamon HealthDay Reporter , ... the counties in the United States lack a single ... graduates gravitate toward metropolitan areas, a new study indicates. ... without obstetrician-gynecologists (ob-gyns); this scarcity is more prevalent in ...
... 2012) The American Gastroenterological Association (AGA) ... (PIM) has received approval from the American ... part of ABIM,s Approved Quality Improvement (AQI) ... internal medicine subspecialists using procedural sedation can ...
... Review: Screening Women for Intimate Partner Violence May Have ... or IPV, includes a range of abusive behaviors perpetrated ... the victim. Abusive behaviors may include physical violence, sexual ... have immediate health effects on the victim. While victims ...
Cached Medicine News:Health News:UC Irvine study finds racial, economic disparities in ovarian cancer care, survival 2Health News:Sperm Collide Along Liquid Maze on Way to Fertilize Egg 2Health News:Block its recycling system, and cancer kicks the can, according to new Penn study 2Health News:Half of U.S. Counties Have No Ob-Gyn: Study 2Health News:AGA releases first independently developed ABIM-approved Practice Improvement Module in GI 2Health News:Annals of Internal Medicine tip sheet for May 8, 2012, online issue 2
(Date:7/28/2014)... 2014  ProteinSimple announced today that it has launched ... assay allows users to detect all proteins separated in ... users can analyze proteins without the need for an ... protein analysis as we know it today. First, the Simple ... no messy gels, no transfer tanks, no blots, no ...
(Date:7/28/2014)... Germany and LONDON ... , Collaboration aims to create and commercialize ... guide the use of IRESSA  for non-small cell lung ... on QIAGEN,s FDA-approved  therascreen   EGFR test and is planned ... automated instruments  Project enabled by AstraZeneca master ...
(Date:7/28/2014)... 28, 2014 OmPrompt today ... to help it meet the global demand for ... and logistics. Albion joins Shackleton Ventures. ... Over the past 18 months OmPrompt has underpinned ... management team and its operations. The new funding ...
Breaking Medicine Technology:ProteinSimple Says "Never Run a Gel Again!" 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 3QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 4QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 5QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 6OmPrompt Funded for Customer Automation Management Market Expansion 2
Protective Curtain for Barriers can be used on any of our RayShield® Barriers. Whether they are ordered with the barrier or as a retrofit, RayShield Protective Curtains are easy to install with s...
Front Protection with attached Belt Guard, Built-in Back Support; Buckle Closure...
Pregnancy Apron...
All Day Comfort for the Upper Body...
Medicine Products: